These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2422788)

  • 1. Modifications in rat hepatobiliary function following treatment with acetone, 2-butanone, 2-hexanone, mirex, or chlordecone and subsequently exposed to chloroform.
    Hewitt LA; Ayotte P; Plaa GL
    Toxicol Appl Pharmacol; 1986 May; 83(3):465-73. PubMed ID: 2422788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the involvement of organelles in the mechanism of ketone-potentiated chloroform-induced hepatotoxicity.
    Hewitt LA; Palmason C; Masson S; Plaa GL
    Liver; 1990 Feb; 10(1):35-48. PubMed ID: 2308479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of biotransformation-detoxication in acetone-, 2-butanone-, and 2-hexanone-potentiated chloroform-induced hepatotoxicity.
    Hewitt LA; Valiquette C; Plaa GL
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2313-8. PubMed ID: 3449191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired biliary excretion of taurocholate associated with increased biliary tree permeability in mirex- or chlordecone-pretreated rats.
    Curtis LR; Hoyt D
    J Pharmacol Exp Ther; 1984 Dec; 231(3):495-501. PubMed ID: 6209385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroform interaction with chlordecone and mirex: correlation between biochemical and histological indices of toxicity and quantitative tissue levels.
    Plaa GL; Caillé G; Vézina M; Iijima M; Côté MG
    Fundam Appl Toxicol; 1987 Aug; 9(2):198-207. PubMed ID: 2443411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The time course of liver injury and [3H]thymidine incorporation in chlordecone-potentiated CHCl3 hepatotoxicity.
    Mehendale HM; Purushotham KR; Lockard VG
    Exp Mol Pathol; 1989 Aug; 51(1):31-47. PubMed ID: 2475365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. I. Dose-response relationships.
    Raymond P; Plaa GL
    J Toxicol Environ Health; 1995 Aug; 45(4):465-80. PubMed ID: 7643433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractional hepatic localization of 14CHCl3 in mice and rats treated with chlordecone or mirex.
    Hewitt LA; Hewitt WR; Plaa GL
    Fundam Appl Toxicol; 1983; 3(6):489-95. PubMed ID: 6198233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-hexanone potentiation of [14C]chloroform hepatotoxicity: covalent interaction of a reactive intermediate with rat liver phospholipid.
    Cowlen MS; Hewitt WR; Schroeder F
    Toxicol Appl Pharmacol; 1984 May; 73(3):478-91. PubMed ID: 6719463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of agents affecting monooxygenase activity on taurolithocholic acid-induced cholestasis.
    Dahlström-King L; Couture J; Plaa GL
    Toxicol Lett; 1992 Dec; 63(3):243-52. PubMed ID: 1283232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response relationships in ketone-induced potentiation of chloroform hepato- and nephrotoxicity.
    Brown EM; Hewitt WR
    Toxicol Appl Pharmacol; 1984 Dec; 76(3):437-53. PubMed ID: 6506071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dietary exposure to a mirex plus chlordecone combination on CCl4 hepatotoxicity.
    Bell AN; Mehendale HM
    Fundam Appl Toxicol; 1985 Aug; 5(4):679-87. PubMed ID: 2412926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms in 2-hexanone potentiation of chloroform hepatotoxicity.
    Cowlen MS; Hewitt WR; Schroeder F
    Toxicol Lett; 1984 Sep; 22(3):293-9. PubMed ID: 6091297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal relationships between biotransformation, detoxication, and chlordecone potentiation of chloroform-induced hepatotoxicity.
    Hewitt LA; Caillé G; Plaa GL
    Can J Physiol Pharmacol; 1986 Apr; 64(4):477-82. PubMed ID: 2425914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirex inhibits bile acid secretory function in vivo and in the isolated perfused rat liver.
    Teo S; Vore M
    Toxicol Appl Pharmacol; 1991 Jun; 109(1):161-70. PubMed ID: 1710079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. II. Implication of monooxygenases.
    Raymond P; Plaa GL
    J Toxicol Environ Health; 1995 Nov; 46(3):317-28. PubMed ID: 7473860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the carbon skeleton length of ketonic solvents and potentiation of chloroform-induced hepatotoxicity in rats.
    Hewitt WR; Brown EM; Plaa GL
    Toxicol Lett; 1983 May; 16(3-4):297-304. PubMed ID: 6857725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of intrarenal biotransformation in chloroform-induced nephrotoxicity in rats.
    Smith JH; Hewitt WR; Hook JB
    Toxicol Appl Pharmacol; 1985 Jun; 79(1):166-74. PubMed ID: 4049404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of chloroform hepatotoxicity and lethality by dietary chlordecone (kepone) in mice.
    Purushotham KR; Lockard VG; Mehendale HM
    Toxicol Pathol; 1988; 16(1):27-34. PubMed ID: 2453913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo metabolism of CCl4 by rats pretreated with chlordecone, mirex, or phenobarbital.
    Mehendale HM; Klingensmith JS
    Toxicol Appl Pharmacol; 1988 Apr; 93(2):247-56. PubMed ID: 2451866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.